Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/10397
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMuhammad, Syamel-
dc.contributor.authorSetiawan, Muhammad Rudy-
dc.date.accessioned2025-06-10T03:05:39Z-
dc.date.available2025-06-10T03:05:39Z-
dc.date.issued2024-04-
dc.identifier.citationResearch Articleen_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/10397-
dc.description.abstractObjective: To determine serum CA-125 examination as predictor in predicting the resectability of advanced ovarian cancer at dr. M. Djamil Padang Methods: The research sample was obtained using a consecutive sampling technique, wherein samples were collected one by one within the specifi ed timeframe until the required sample size was achieved. Results: The mean CA-125 level among respondents was 589.66 U/mL with a standard deviation of 841.55 U/mL. The study also revealed that a CA-125 cutoff value of 337.5 U/mL demonstrated high sensitivity (92.31%) and specifi city (90.90%) in predicting the resectability of ovarian cancer. Conclusion: Serum CA-125 examination shows a promising result in predicting the resectability of advanced ovarian cancer at dr. M. Djamil Padangen_US
dc.language.isoen_USen_US
dc.publisherIndones J Obstet Gynecolen_US
dc.subjectCA-125en_US
dc.subjectconsecutive sampling techniqueen_US
dc.subjectovarian canceren_US
dc.titleCA-125 Examination as a Predictor the Resectability of Advanced Stage of Ovarian Canceren_US
dc.typeArticleen_US
Appears in Collections:Volume 12 No 2 2024

Files in This Item:
File Description SizeFormat 
7.pdf89.54 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.